<p>多年来，DocuSign Inc NASDAQ: DOCU 一直是市场上最受欢迎的失望之一。曾经在疫情期间备受青睐的它，在过去几年中大部分时间都陷入了一个似乎无尽的错失机会和投资者热情减退的循环中。它还发现自己在人工智能革命的错误一方，导致其股票在今年早些时候下跌超过 40%。</p>
<p>然而，最近几周情况开始发生变化。在周四晚上的财报发布之前，自 5 月中旬以来，股价上涨了大约 30%，投资者对 DocuSign 能够实现类似 HubSpot Inc NYSE: HUBS 的转型感到兴奋。</p>
<p>然后是周四的报告。尽管公司超出预期并提高了前瞻性指引，但股票却大幅下跌，分析师们并不满意。乍一看，这种反应似乎是合理的，但深入分析后，可以认为市场关注的焦点是错误的。</p>
<h2>本季度表现好于市场反应所暗示的</h2>
<p>DocuSign 的主要数据再次表现出色，轻松超出预期，展现出越来越令人印象深刻的一致性。对于一家试图说服市场其能够实现持续复苏的公司来说，这正是你希望围绕季度报告构建的业绩记录。此外，管理层提高了收入展望，而盈利能力和自由现金流也都令人印象深刻。</p>
<p>除此之外，管理层指出对 DocuSign 的 AI 原生智能协议管理（IAM）平台的需求不断增长，超过 40,000 个客户已经投资于该产品。对于一家在过去几年中努力说服投资者其在电子签名之外有可信增长故事的公司来说，这是一个重要的发展。这也与我们看到的传统软件公司试图与 AI 合作而不是对抗的更广泛趋势相契合。</p>
<h2>但逆风依然存在</h2>
<p>然而，问题在于投资者和分析师不仅在寻找更引人注目的东西，还发现了原本乐观展望中的一些薄弱环节。</p>
<p>例如，DocuSign 的年度经常性收入指引保持不变，增长率为 8.5%，许多人认为这是进入报告前最重要的指标。此外，市场对公司 IAM 增长轨迹的可见性仍然有限。这些原因足以让美国银行维持其表现不佳的评级。</p>
<p>摩根士丹利也采取了类似的谨慎态度。尽管承认执行力强和 IAM 采用率上升，但它认为该平台的经济性仍然难以评估。尽管如此，它维持了对该股票的平等权重评级，其目标价为 69 美元，表明市场的反应过于负面。DocuSign 的股票在周五交易开始时约为 50 美元，这意味着看空的摩根士丹利目标价大约有 40% 的上涨空间。</p>
<h2>华尔街希望在故事完全展开之前看到证据</h2>
<p>看涨的论点很强。愿意倾向于乐观论点的人认为 DocuSign 是一家成功将自己从单一产品提供商转型为更广泛的协议管理平台的公司。他们看到客户采用率的增加、产品范围的扩大，以及 AI 驱动的工作流程创造全新货币化机会的潜力。</p>
<p>重要的是，管理层依然充满信心，并在最近几个月以创纪录的水平回购股票。这些通常不是你会期望在经历生存危机的公司身上看到的事情。</p>
<p>市场的挑战在于，这些好处尚未完全体现在预期的增长率中，令投资者感到沮丧。在一个许多股票因接近垂直的增长率而迅速上涨的市场中，选择投资 DocuSign 的机会成本相当高。</p>
<h2>为什么抛售可能是一个机会</h2>
<p>尽管如此，现在看涨的理由比看跌的理由更多，尤其是考虑到股票的抛售幅度。公司超出预期，提高了前瞻性指引，回购了自己的股票，并在其 AI 举措中交出了令人鼓舞的结果。</p>
<h3>Docusign Inc. (DOCU) 2026 年 6 月 8 日的价格图表</h3>
<p>尽管它可能没有以投资者期望的速度，或与其他软件股票相似的速度进行所有这些操作，但它仍然保持着稳健的向前势头。在这种背景下，DocuSign 的股票仍然接近多年来的低点，这意味着当前的风险回报特征特别有吸引力。</p>
<h2>你现在应该投资 1000 美元在 Docusign 吗？</h2>
<p>在考虑 Docusign 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Docusign 并不在名单上。</p>
<p>虽然 Docusign 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

DOCU

<p>尽管 DocuSign (DOCU) 超过了盈利预期并提高了指引，但其股价仍然下跌，这主要是由于年度经常性收入增长预测未变以及对其人工智能平台经济状况的可见性有限。尽管像美国银行这样的分析师保持谨慎，但该公司在 IAM 采用方面表现出强劲的执行力，并创下了股票回购的新纪录。该股交易接近多年低点，为押注其超越电子签名转型的投资者提供了一个潜在吸引人的风险回报配置</p>

<p>For years, DocuSign Inc NASDAQ: DOCU has been one of the market's favorite disappointments. What was once a pandemic-era darling has spent much of the last few years trapped in a seemingly endless cycle of missed opportunities and fading investor enthusiasm. It’s also found itself on the wrong side of the AI revolution, which sent its stock down by more than 40% earlier this year.</p>
<div class="lb-trans"><p>多年来，DocuSign Inc NASDAQ: DOCU 一直是市场上最受欢迎的失望之一。曾经在疫情期间备受青睐的它，在过去几年中大部分时间都陷入了一个似乎无尽的错失机会和投资者热情减退的循环中。它还发现自己在人工智能革命的错误一方，导致其股票在今年早些时候下跌超过 40%。</p>
</div><p>Yet something had started to change in recent weeks. Before Thursday night’s earnings release, shares had rallied roughly 30% since the middle of May as investors grew excited about the potential for DocuSign to pull off a HubSpot Inc NYSE: HUBS style pivot.</p>
<div class="lb-trans"><p>然而，最近几周情况开始发生变化。在周四晚上的财报发布之前，自 5 月中旬以来，股价上涨了大约 30%，投资者对 DocuSign 能够实现类似 HubSpot Inc NYSE: HUBS 的转型感到兴奋。</p>
</div><p>Then came Thursday's report. Despite the company beating expectations and raising forward guidance, the stock sold off sharply, and analysts weren’t impressed. At first glance, this reaction looks justified, but dig a little deeper, and there’s an argument that the market is focusing on the wrong things.</p>
<div class="lb-trans"><p>然后是周四的报告。尽管公司超出预期并提高了前瞻性指引，但股票却大幅下跌，分析师们并不满意。乍一看，这种反应似乎是合理的，但深入分析后，可以认为市场关注的焦点是错误的。</p>
</div><h2>The Quarter Was Better Than the Market Reaction Suggests</h2>
<div class="lb-trans"><h2>本季度表现好于市场反应所暗示的</h2>
</div><p>With what is becoming impressive consistency, DocuSign’s headline numbers were once again solid and comfortably beat expectations. For a company trying to convince the market it’s capable of making a sustained comeback, that’s exactly the kind of track record you want to be framing quarterly reports around. In addition, management increased its revenue outlook, while profitability and free cash flow were both impressive.</p>
<div class="lb-trans"><p>DocuSign 的主要数据再次表现出色，轻松超出预期，展现出越来越令人印象深刻的一致性。对于一家试图说服市场其能够实现持续复苏的公司来说，这正是你希望围绕季度报告构建的业绩记录。此外，管理层提高了收入展望，而盈利能力和自由现金流也都令人印象深刻。</p>
</div><p>Beyond that, executives pointed to growing demand for DocuSign's AI-native Intelligent Agreement Management, or IAM, platform, noting that more than 40,000 customers have now invested in the offering. For a company that spent much of the last several years struggling to convince investors it had a credible growth story beyond electronic signatures, that’s a meaningful development. It also ties in well with the broader trend we’re seeing with traditional software companies trying to work with AI, rather than against it.</p>
<div class="lb-trans"><p>除此之外，管理层指出对 DocuSign 的 AI 原生智能协议管理（IAM）平台的需求不断增长，超过 40,000 个客户已经投资于该产品。对于一家在过去几年中努力说服投资者其在电子签名之外有可信增长故事的公司来说，这是一个重要的发展。这也与我们看到的传统软件公司试图与 AI 合作而不是对抗的更广泛趋势相契合。</p>
</div><h2>But the Headwinds Are Still There</h2>
<div class="lb-trans"><h2>但逆风依然存在</h2>
</div><p>However, the problem is that investors and analysts were not only looking for something much more eye-catching, but also saw some weak spots in the otherwise rosy outlook.</p>
<div class="lb-trans"><p>然而，问题在于投资者和分析师不仅在寻找更引人注目的东西，还发现了原本乐观展望中的一些薄弱环节。</p>
</div><p>DocuSign’s annual recurring revenue guidance, for example, remained unchanged at 8.5% growth, which many had viewed as the most important metric heading into the report. There was also a sense that visibility into the company’s IAM growth trajectory remains limited. These reasons alone were enough for Bank of America to maintain its Underperform rating.</p>
<div class="lb-trans"><p>例如，DocuSign 的年度经常性收入指引保持不变，增长率为 8.5%，许多人认为这是进入报告前最重要的指标。此外，市场对公司 IAM 增长轨迹的可见性仍然有限。这些原因足以让美国银行维持其表现不佳的评级。</p>
</div><p>Morgan Stanley struck a similarly cautious tone. While acknowledging strong execution and growing IAM adoption, it argued that the platform's economics remain difficult to evaluate. Still, it maintained its Equal-weight rating on the stock, and its price target of $69 suggests the market’s reaction has been way too negative. DocuSign shares were trading around $50 at the start of Friday’s session, which means bearish Morgan Stanley is targeting roughly 40% upside from here.</p>
<div class="lb-trans"><p>摩根士丹利也采取了类似的谨慎态度。尽管承认执行力强和 IAM 采用率上升，但它认为该平台的经济性仍然难以评估。尽管如此，它维持了对该股票的平等权重评级，其目标价为 69 美元，表明市场的反应过于负面。DocuSign 的股票在周五交易开始时约为 50 美元，这意味着看空的摩根士丹利目标价大约有 40% 的上涨空间。</p>
</div><h2>Wall Street Wants Proof Before the Story Fully Plays Out</h2>
<div class="lb-trans"><h2>华尔街希望在故事完全展开之前看到证据</h2>
</div><p>The bullish argument is strong. Those willing to lean into the glass-half-full thesis see DocuSign as a company successfully transforming itself from a single-product provider into a broader agreement management platform. They see increasing customer adoption, growing product breadth, and the potential for AI-powered workflows to create entirely new monetization opportunities.</p>
<div class="lb-trans"><p>看涨的论点很强。愿意倾向于乐观论点的人认为 DocuSign 是一家成功将自己从单一产品提供商转型为更广泛的协议管理平台的公司。他们看到客户采用率的增加、产品范围的扩大，以及 AI 驱动的工作流程创造全新货币化机会的潜力。</p>
</div><p>Importantly, management remains confident and has been repurchasing shares at record levels in recent months. These aren’t typically things you’d expect from a company going through an existential crisis.</p>
<div class="lb-trans"><p>重要的是，管理层依然充满信心，并在最近几个月以创纪录的水平回购股票。这些通常不是你会期望在经历生存危机的公司身上看到的事情。</p>
</div><p>The market's challenge is that these benefits have not yet fully materialized in projected growth rates, leaving investors frustrated. In a market where there are plenty of stocks ripping higher off the back of near-vertical growth rates, choosing to invest in DocuSign carries some pretty high opportunity costs.</p>
<div class="lb-trans"><p>市场的挑战在于，这些好处尚未完全体现在预期的增长率中，令投资者感到沮丧。在一个许多股票因接近垂直的增长率而迅速上涨的市场中，选择投资 DocuSign 的机会成本相当高。</p>
</div><h2>Why the Selloff Could Be an Opportunity</h2>
<div class="lb-trans"><h2>为什么抛售可能是一个机会</h2>
</div><p>All that being said, there are more reasons to be bullish than bearish right now, especially when you consider how much the stock has sold off. The company is beating expectations, raising forward guidance, buying back its own shares and delivering promising results from its AI initiatives.</p>
<div class="lb-trans"><p>尽管如此，现在看涨的理由比看跌的理由更多，尤其是考虑到股票的抛售幅度。公司超出预期，提高了前瞻性指引，回购了自己的股票，并在其 AI 举措中交出了令人鼓舞的结果。</p>
</div><h3>Docusign Inc. (DOCU) Price Chart for Monday, June, 8, 2026</h3>
<div class="lb-trans"><h3>Docusign Inc. (DOCU) 2026 年 6 月 8 日的价格图表</h3>
</div><p>It might not be doing all of this at the pace investors might expect, or at a pace similar to other software stocks, but it’s still solid forward momentum. Against that backdrop, DocuSign shares continue to trade close to multi-year lows, which means the risk-reward profile is particularly attractive right now.</p>
<div class="lb-trans"><p>尽管它可能没有以投资者期望的速度，或与其他软件股票相似的速度进行所有这些操作，但它仍然保持着稳健的向前势头。在这种背景下，DocuSign 的股票仍然接近多年来的低点，这意味着当前的风险回报特征特别有吸引力。</p>
</div><h2>Should You Invest $1,000 in Docusign Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Docusign 吗？</h2>
</div><p>Before you consider Docusign, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Docusign 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Docusign 并不在名单上。</p>
</div><p>While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Docusign 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Docusign: Another Beat, Another Selloff—Why the Analysts Are Wrong

Market Beat

Docusign

HubSpot

美国银行

摩根士丹利

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

Docusign：再一次超出预期，再一次遭遇抛售——分析师为何判断失误